Manapad, Isnaira B.

HRN: 12-96-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
AMPICILLIN 250MG (VIAL)
04/20/2022
04/27/2022
IV
110MG
Q12H
PROM X 48 HRS
04/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/20/2022
04/27/2022
IVTT
11MG
Q24H
PROM X 48 HRS

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: